In the latest trading session, 2.08 million Aptevo Therapeutics Inc (NASDAQ:APVO) shares changed hands as the company’s beta touched 5.00. With the company’s most recent per share price at $0.23 changed hands at -$0.05 or -16.48% at last look, the market valuation stands at $3.52M. APVO’s current price is a discount, trading about -4595.65% off its 52-week high of $10.80. The share price had its 52-week low at $0.14, which suggests the last value was 39.13% up since then. When we look at Aptevo Therapeutics Inc’s average trading volume, we note the 10-day average is 2.85 million shares, with the 3-month average coming to 6.87 million.
Aptevo Therapeutics Inc (NASDAQ:APVO) trade information
Instantly APVO was in red as seen in intraday trades today. With action -23.97%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -97.06%, with the 5-day performance at -23.97% in the red. However, in the 30-day time frame, Aptevo Therapeutics Inc (NASDAQ:APVO) is -13.35% down. Looking at the short shares, we see there were 0.73 million shares sold at short interest cover period of 0.05 days.
Aptevo Therapeutics Inc (APVO) estimates and forecasts
Data shows that the Aptevo Therapeutics Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -70.31% over the past 6 months, a 95.86% in annual growth rate that is considerably higher than the industry average of 17.70%.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 46.80%. The 2024 estimates are for Aptevo Therapeutics Inc earnings to decrease by -81.72%.
APVO Dividends
Aptevo Therapeutics Inc is expected to release its next quarterly earnings report in January.
Aptevo Therapeutics Inc (NASDAQ:APVO)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.03% of Aptevo Therapeutics Inc shares while 11.36% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 11.36%.
